| Literature DB >> 35326103 |
Amel Bouzabata1, Paola Montoro2, Katarzyna Angelika Gil3, Sonia Piacente2, Fadia S Youssef4, Nawal M Al Musayeib5, Geoffrey A Cordell6,7, Mohamed L Ashour4, Carlo Ignazio Giovanni Tuberoso3.
Abstract
This study aimed to assess and correlate the phenolic content and the antioxidant activity of the methanol extracts of the stems, roots, flowers, and leaves of Echinops spinosus L. from north-eastern Algeria. Qualitative analysis was performed by high-resolution mass spectrometry (HR) LC-ESI-Orbitrap-MS and (HR) LC-ESI-Orbitrap-MS/MS). Forty-five compounds were identified in the methanol extracts; some are described for the first time in E. spinosus. Targeted phenolic compounds were quantified by HPLC-DAD and it was shown that caffeoyl quinic derivatives were the most abundant compounds. Chemometric analysis was performed using principal component analysis (PCA) and hierarchical cluster analysis (HCA) based on the qualitative and quantitative LC data. The score plot discriminates different Echinopsis spinosus organs into three distinct clusters, with the stems and flowers allocated in the same cluster, reflecting their resemblance in their secondary metabolites. The antioxidant activities of the methanol extracts were assessed using cupric reducing antioxidant capacity (CUPRAC), ferric reducing antioxidant assay (FRAP), diphenyl picryl hydrazyl radical-scavenging capacity assay (DPPH●), and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS●+). The root extract exhibited the highest antioxidant activity, evidenced by 3.26 and 1.61 mmol Fe2+/g dried residue for CUPRAC and FRAP, respectively, and great free radical-scavenging activities estimated by 0.53 and 0.82 mmol TEAC/g dried residue for DPPH● and ABTS●+, respectively. The methanol extract of the roots demonstrated a significant level of total phenolics (TP: 125.16 mg GAE/g dried residue) and flavonoids (TFI: 25.40 QE/g dried residue TFII: 140 CE/g dried residue). Molecular docking revealed that tricaffeoyl-altraric acid and dicaffeoyl-altraric acid exhibited the best fit within the active sites of NADPH oxidase (NO) and myeloperoxidase (MP). From ADME/TOPAKT analyses, it can be concluded that tricaffeoyl-altraric acid and dicaffeoyl-altraric acid also revealed reasonable pharmacokinetic and pharmacodynamic characteristics with a significant safety profile.Entities:
Keywords: ADME/TOPAKT; Echinops; HPLC-DAD; antioxidant activity; chemometrics; phenolics
Year: 2022 PMID: 35326103 PMCID: PMC8944760 DOI: 10.3390/antiox11030453
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Qualitative identification of major compounds in E. spinosus extracts (S, stems; R, roots; F, flowers; L, leaves; X, present; -, absent) by LC-ESI-Orbitrap-MS and LC-ESI-Orbitrap-MS/MS analysis.
| Peak No. | Rt | [M − H]− | Molecular Formula | Δ Ppm | MS/MS | Identity | S | R | F | L | References |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1.87 | 377.0855 | C18H17O9 | −3.258 | 341.11 | Caffeic acid derivative | X | X | - | - | [ |
| 2 | 1.91 | 191.0563 | C7H11O6 | 6.833 | 85.03/93.04/127.04/173.05 | Quinic acid | X | - | - | X | [ |
| 3 | 5.83 | 329.0871 | C14H17O9 | 1.281 | 167.04 | Unknown | - | - | - | X | - |
| 4 | 6.06 | 315.0715 | C13H15O9 | 1.592 | 153.02 | Protocatechuic acid hexoside | X | X | X | X | [ |
| 5 | 6.33 | 359.0747 | C18H15O8 | −3.77 | 197.05 | Syringic acid glycoside | - | - | X | - | [ |
| 6 | 7.24 | 353.0872 | C16H17O9 | 1.449 | 179.03/191.06 | Neochlorogenic acid (3-CQA) | - | X | X | X | [ |
| 7 | 8.46 | 353.0872 | C16H17O9 | 1.449 | 179.03/191.06 | Chlorogenic acid (5-CQA) | X | X | X | X | [ |
| 8 | 9.65 | 533.0929 | C24H21O14 | 0.597 | 371.06/209.03 | Dicaffeoyl altraric acid | X | X | - | - | [ |
| 9 | 9.96 | 515.1187 | C25H23O12 | 0.713 | 353.09 | 3,5-Dicaffeoylquinic acid | - | X | - | X | [ |
| 10 | 10.93 | 565.1919 | C27H33O13 | 0.695 | 327.12/339.12 | Unknown | X | - | - | - | |
| 11 | 11.16 | 677.1714 | C31H33O17 | 0.242 | 515.14/353.09 | Dicaffeoylquinic acid glycoside | X | - | - | [ | |
| 12 | 11.42 | 533.09271 | C24H21O14 | 0.241 | 371.06 | Dicaffeoyl altraric isomer acid | - | X | - | - | [ |
| 13 | 11.78 | 563.1417 | C26H27O14 | 3.860 | - | Apigenin-6- | - | - | X | - | [ |
| 14 | 12.43 | 515.1182 | C25H23O12 | −0.587 | 353.08 | 3,4-Dicaffeoylquinic acid | X | X | X | X | [ |
| 15 | 12.47 | 563.1417 | C26H27O14 | 3.860 | - | Apigenin-6- | - | - | X | - | [ |
| 16 | 12.89 | 515.1182 | C25H23O12 | 1.781 | 353.08 | 3,5-Dicaffeoylquinic acid | X | X | X | X | [ |
| 17 | 13.24 | 515.1187 | C25H23O12 | 0.248 | 353.08 | 4,5-Dicaffeoylquinic acid | X | X | X | X | [ |
| 18 | 13.40 | 447.0932 | C21H19O11 | 1.101 | - | Luteolin-7- | - | - | X | - | [ |
| 19 | 14.09 | 695.1241 | C33H27O17 | 0.337 | 533.09/371.06 | Tricaffeoylaltraricric acid | X | X | - | - | [ |
| 20 | 14.20 | 499.1237 | C25 H23 O11 | 0.585 | 353.09/337.09/191.06 | 3- | X | - | - | X | [ |
| 21 | 14.34 | 609.1602 | C27H29O16 | 1.010 | 301 | Rutin | - | - | X | - | [ |
| 22 | 14.57 | 399.3621 | C28H47O | −0.107 | 152.01/153.02/315.07 | Campesterol | - | - | X | - | [ |
| 23 | 15.55 | 435.0920 | C20H19O11 | −0.340 | 297.06/315.07 | Shimobashiraside C | X | - | - | X | [ |
| 24 | 15.95 | 411.3617 | C29H47O | −0954 | 315.07 | Stigmasterol | - | - | X | - | [ |
| 25 | 16.07 | 577.1341 | C30H25O12 | 0.060 | 269.05 | Apigenin-7- | - | - | X | X | [ |
| 26 | 16.17 | 357.1914 | C18H29O7 | 1.765 | 198.02 | Unknown | - | - | - | X | - |
| 27 | 16.42 | 582.2596 | C21H44O17N | −1.360 | 462.20 | Unknown | - | - | X | - | - |
| 28 | 16.84 | 327.2174 | C18H31O5 | 2.290 | 171.10/211.13/229.14/291.20 | 9,12,13-TriHODE (10,15) | X | X | X | [ | |
| 29 | 16.88 | 385.3458 | C27H45O | −1.610 | - | Cholesterol | - | - | X | - | [ |
| 30 | 17.09 | 397.3451 | C28H45O | −3.501 | - | Brassicasterol | - | - | X | - | [ |
| 31 | 17.16 | 519.1862 | C26H31O11 | 0.370 | 213.09/475.20 | Unknown | - | X | - | - | - |
| 32 | 17.29 | 665.3169 | C34H49O13 | 0.289 | 503.29 | Unknown | X | - | - | - | - |
| 33 | 17.76 | 329.2330 | C18H33O5 | 2.276 | 211.13/229.14 | 9,12,13-TriHODE (10) | X | X | - | - | [ |
| 34 | 17.79 | 577.1343 | C30H25O12 | 0.491 | 269.04/413.09/431.10 | Apigenin-7-β- | - | - | X | X | [ |
| 35 | 17.90 | 609.1602 | C27H29O16 | 2.011 | - | Hesperidin | - | - | X | - | [ |
| 36 | 18.26 | 579.1497 | C30H27O12 | 1.022 | 271.06/307.08 | Naringenin-coumaroyl-glucoside | - | - | X | X | [ |
| 37 | 18.31 | 605.1866 | C29 H33 O14 | 0.271 | 561.20 | Unknown | - | X | - | - | - |
| 38 | 18.31 | 299.0556 | C16 H11 O6 | 1.990 | - | Hispidulin | - | X | - | - | [ |
| 39 | 18.37 | 609.1603 | C27H29O16 | 2.010 | - | Luteolin-Ara-Glu or Luteolin-Glu-Ara | - | - | X | - | [ |
| 40 | 18.62 | 619.1443 | C32H27O13 | −1.040 | 269 | Apigenin derivative | - | - | X | X | [ |
| 41 | 23.84 | 445.2431 | C22H37O9 | −0.178 | 198.01/283.86 | Unknown | - | X | - | - | - |
| 42 | 26.56 | 761.2856 | C34H49O19 | −0.808 | 198.00/283.86/633.24 | Unknown | - | X | - | - | - |
| 43 | 29.55 | 295.2273 | C18H31O3 | 2.096 | 171.10/277.22 | 10,12-Octadecadienoic acid, 9-hydroxy- | - | X | - | - | [ |
| 44 | 33.27 | 513.3062 | C27H45O9 | 0.781 | 198.01/283.86 | Unknown | - | X | - | - | - |
| 45 | 36.98 | 271.0607 | C16H17O9 | 0.101 | - | Naringenin | - | - | X | - | [ |
Figure 1LC-ESI-Orbitrap-MS of extract obtained from the stems (A), roots (B), flowers (C), and leaves (D) of Echinopsis spinosus L.
Concentration of targeted polar compounds (mg/g dried residue) in E. spinosus L. extracts (mean ± SD, n = 3).
| Compound | Identification a | Extract (mg/g Dried Residue) | |||
|---|---|---|---|---|---|
| Stems | Roots | Flowers | Leaves | ||
| Hydroxy cinnamic acid derivatives | 135.28 ± 1.42 | 330.20 ± 0.98 | 105.95 ± 0.41 | 284.86 ± 2.9 | |
| Neochlorogenic acid (NCGA, 3-CQA) | Rt, UV-Vis, MS | 1.54 ± 0.22 | 2.19 ± 0.14 | 1.51 ± 0.07 | 4.77 ± 0.57 |
| Chlorogenic acid (CGA, 5-CQA) | Rt, UV-Vis, MS | 22.56 ± 0.25 | 46.01 ± 0.56 | 17.18 ± 0.34 | 74.30 ± 1.92 |
| Dicaffeoyl altraric acid b | UV-Vis, MS | 4.14 ± 4.24 | 35.95 ±0.02 | 1.10 ± 0.02 | 3.83 ± 0.12 |
| Dicaffeoylquinic acid (diCQA) b | UV-Vis, MS | 2.71 ± 0.13 | 6.68 ± 0.19 | 0.29 ± 0.01 | 1.76 ± 0.08 |
| 3,4-Dicaffeoylquinic acid b | UV-Vis, MS | 4.58 ± 0.01 | 16.18 ± 0.72 | 10.34 ± 0.01 | 3.69 ± 0.1 |
| 3,5-Dicaffeoylquinic acid | Rt, UV-Vis, MS | 44.13 ± 2.69 | 93.11± 3.13 | 45.50 ± 1.25 | 68.79 ± 0.22 |
| 4,5-Dicaffeoylquinic acid b | UV-Vis, MS | 40.57 ± 1.15 | 91.12 ± 1.34 | 29.26 ± 0.54 | 104.85 ± 9.02 |
| Tricaffeoyl-altraric acid b | UV-Vis, MS | 6.84 ± 0.32 | 38.97 ± 1.32 | 0.76 ± 0.07 | 5.94 ± 0.5 |
| Coumaroyl-caffeoylquinic acid c | UV-Vis, MS | 8.22 ± 0.64 | tr | tr | 17.44 ± 0.34 |
| Flavonoids | tr | 3.98 ± 0.21 | 21.32 ± 0.08 | 8.55 ± 0.07 | |
| Apigenin-6-arabinoside-8-galactosided | UV-Vis, MS | nd | nd | 1.87 ± 0.01 | nd |
| Apigenin 6-arabinoside-8-glucoside d | UV-Vis, MS | nd | nd | 0.92 ± 0.01 | nd |
| Luteolin-7- | Rt, UV-Vis, MS | tr | tr | 1.91 ± 0.01 | tr |
| Quercetin-3-rutinoside (rutin) | Rt, UV-Vis, MS | nd | nd | 1.65 ± 0.23 | nd |
| Apigenin-7- | UV-Vis, MS | tr | tr | 1.32 ± 0.01 | 3.68 ± 0.05 |
| Apigenin-7- | UV-Vis, MS | nd | nd | 1.81± 0.01 | 2.07 ± 0.02 |
| Hesperetin-7-rutinoside (Hesperidin) | Rt, UV-Vis, MS | tr | tr | 3.00 ± 0.07 | tr |
| Naringenin-coumaroyl-glucoside f | UV-Vis, MS | tr | tr | 4.01 ± 0.23 | 1.36 ± 0.02 |
| Hispidulin | Rt, UV-Vis, MS | tr | 3.98 ± 0.21 | nd | nd |
| Luteolin ara-glu/glu-ara e | UV-Vis, MS | nd | nd | 0.94 ± 0.03 | nd |
| Apigenin glucosidated d | UV-Vis, MS | nd | nd | 3.02 ± 0.02 | 1.44 ± 0.06 |
| Naringenin | Rt, UV-Vis, MS | nd | nd | 0.88 ± 0.03 | nd |
| Hydroxybenzoic acid derivatives | 2.46 ± 0.001 | 2.90 ± 0.08 | 0.93 ± 0.02 | 5.52 ± 0.01 | |
| Protocatecuic acid hexoside g | UV-Vis, MS | 1.31 ± 0.04 | 2.90 ± 0.08 | 0.93 ± 0.02 | 2.66 ± 0.1 |
| Shimobashiraside C g | UV-Vis, MS | 1.15 ± 0.04 | tr | tr | 2.86 ± 0.09 |
a: Rt, comparison with retention time of pure standard; UV-Vis, comparison with UV-VIS spectra of pure compound or similar pure standards; MS, MS/MS spectra fragmentation patterns reported in the literature as described in Table 1. b: Determined with the calibration curve of 3,5-dicaffeoylquinic acid. c: Determined with the calibration curve of chlorogenic acid. d: Determined with the calibration curve of apigenin-7-O-glucoside. e: Determined with the calibration curve of luteolin-7-O-glucoside. f: Determined with the naringenin calibration curve. g: Determined with the protocatechuic acid calibration curve. The results are reported as mean value ± standard deviation (n = 3); nd: not detected (
Figure 2LC-based chemometrics analysis of different Echinopsis spinosus L. organs. (A) Score plot; (B) loading plot; (C) HCA.
Antioxidant capacities, total phenols, and total flavonoids of different E. spinosus extracts (per g of extract dry residue).
| Samples | CUPRAC a | FRAP a | DPPH● b | ABTS●+ b | TP c | TF I d | TF II e |
|---|---|---|---|---|---|---|---|
| Stems | 2.03 ± 0.09 a | 0.89 ± 0.04 a | 0.37 ± 0.02 a | 0.47 ± 0.03 ac | 83.60 ± 3.64 a | 10.64 ± 1.63 a | 105.41 ± 2.79 a |
| Roots | 3.26 ± 0.19 b | 1.61 ± 0.14 b | 0.53 ± 0.01 b | 0.82 ± 0.04 b | 125.16 ± 9.48 b | 25.40 ± 1.76 b | 140.12 ± 1.48 b |
| Flowers | 2.50 ± 0.12 c | 1.06 ± 0.08 c | 0.42 ± 0.03 ac | 0.52 ± 0.02 ac | 97.59 ± 4.25 c | 9.22 ± 1.31 a | 124.71 ± 7.95 c |
| Leaves | 2.37 ± 0.30 ac | 1.02 ± 010 ac | 0.47 ± 0.02 c | 0.46 ± 0.02 a | 121.50 ± 11.25 b | 13.15 ± 0.73 c | 138.10 ± 1.94 d |
a FRAP (ferric ion-reducing antioxidant power) and CUPRAC (cupric ion-reducing antioxidant capacity) values are expressed as Fe2+ millimolar concentration, obtained from a FeSO4 solution with an antioxidant capacity equivalent to that of the dilution of the dry extract residue; mmol Fe2+/g dried residue. b DPPH● (1.1-diphenyl-2-picrylhydrazylradical) and ABTS●+ (2.2′-azino-bis(3-ethylbenzothiazoline-6-sulfonate radical cation) values are expressed as TEAC millimolar concentration, obtained from a Trolox solution with an antiradical capacity equivalent to that of the dilution of the dry extract residue; mmol TEAC/g dried residue. c GAE: gallic acid equivalent; mg GAE/g dried residue. d QE: quercetin equivalent; mg QE/g dried residue. e CE: catechin equivalent; mg CE/g dried residue. Results are reported as the mean value ± standard deviation (n = 3). Means in the same column that do not share a letter are significantly different (p ≤ 0.05).
Binding energies (kcal/mol) of the major polar compounds in the E. spinosus L. extracts within the active sites of NADPH oxidase (NO) and myeloperoxidase (MP).
| Compounds | NADPH Oxidase (NO) | Number of Formed Hydrogen Bonds with the Amino Acid Residues | Myeloperoxidase (MP) | Number of Formed Hydrogen Bonds with the Amino Acid Residues |
|---|---|---|---|---|
| Apigenin 6-arabinoside-8-glucoside | 11.64 | 7; Asp282, Glu163, Ala45, Lys134, Csx 42 | −1.44 | 4; Met422, Gln420, Gly493 |
| Apigenin-6-arabinoside-8-galactoside | −5.06 | 6; Asp282, Glu163, Lys134, Ser 115 | 14.14 | 5; Gly476, Asp447, Met479, Gln452 |
| Chlorogenic acid | −40.01 | 7; Lys134, Ser115, Asn34, Asn36, Tyr 136 | −36.55 | 6; Asp447, Asp474, Gly476, Gln420, Met422 |
| Coumaroyl-caffeoylquinic acid | −60.80 | 5; Asp282, Lys134, Csx42, His 10, Ala11 | −44.42 | 6; ; Asp447, Asp474, Met479. Gln482, Lys487, Glu484 |
| Dicaffeoyl altraric acid | −81.8 | 9; Asp282, Glu163, Ala45, Lys134, His 10, ALa300, Pro 298 | −60.52 | 7; Asp474, Thr90, Gln419, Gln420, Ser396, Tyr543, Trp472 |
| Dicaffeoylquinic acid | −58.16 | 5; Asp282, Glu32, Lys134, Ile 160, Csx42 | −49.41 | 4; ; Asp447, Asp474, Ser396, Gln19, Gln420 |
| Hesperidin | −11.43 | 5; Lys134, Asn135, Thr9, Thr112, Ala11 | −4.23 | 2; Gln420, Met479 |
| Hispidulin | −37.67 | 2; Asp282 | −30.34 | 3; Asp474, Gln420, Gly476 |
| Luteolin-7- | −33.70 | 7; Asp282, Lys134, Pro 298, Csx42, ALa300, Glu32 | −15.23 | 5; Asp447, Asp474, Gln420, Gly476, Tyr543 |
| Naringenin-coumaroyl-glucosid | −38.22 | 6; Ala45, Ser41, Lys134, Asn34, Asp282 | −23.75 | 2; Asp474, Tyr543 |
| Naringenin | −36.05 | 3; Asp282, Glu32 | −30.90 | 3; Asp447, Asp474, Gly476 |
| Neochlorogenic acid | −42.63 | 6; Asp282, Lys134, Pro 298, ALa300, Glu32 | −37.49 | 5; Asp447, Asp474, Gln420, Gln483, Ser396 |
| Rutin | −12.13 | 8; Asp282, Lys134, Pro 298, Ser41, Asn34, Asn36, Met33 | 2.41 | 3; Asp447, Thr421, Gln419 |
| Tricaffeoyl-altraric acid | −93.93 | 13; Asp282, Lys134, Ser41, Asn34, Asn36, Glu32, Ala11, Csx42, Gly329, Leu299 | −75.35 | 8; His554, Gln483, Met479, Asp447, Aasn478, Gln420, Gln452 |
Positive values indicate unfavorable interaction.
Figure 32D and 3D binding mode of tricaffeoyl-altraric acid (A) and dicaffeoyl-altraric acid (B) identified in different Echinopsis spinosus L. organs in the binding site of NADPH oxidase (NO).
Figure 42D and 3D binding mode of tricaffeoyl-altraric acid (A) and dricaffeoyl-altraric acid (B) identified in different Echinopsis spinosus L. organs in the binding site of myeloperoxidase (MP).
ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of E. spinosus major phenolic compounds.
| Compounds | Absorption Level | Solubility Level | BBB Level | PPB Level | CPY2D6 | Hepatotoxic | PSA-2D | Alog p98 |
|---|---|---|---|---|---|---|---|---|
| Apigenin 6-arabinoside-8-glucoside | 3 | 2 | 4 | False | Inh. | Toxic | −1.90 | 252.25 |
| Apigenin-6-arabinoside-8-galactoside | 3 | 2 | 4 | False | NI | NT | −1.86 | 252.25 |
| Chlorogenic acid | 3 | 4 | 4 | False | NI | NT | −0.34 | 168.42 |
| Coumaroyl-caffeoylquinic acid | 3 | 3 | 4 | False | NI | NT | 1.93 | 194.66 |
| Dicaffeoyl altraric acid | 3 | 2 | 4 | False | NI | NT | 1.37 | 253.59 |
| Dicaffeoylquinic acid | 3 | 2 | 4 | False | NI | NT | 1.69 | 215.47 |
| Hesperidin | 3 | 2 | 4 | False | NI | Toxic | −0.43 | 237.41 |
| Hispidulin | 0 | 3 | 3 | False | NI | Toxic | 2.39 | 97.61 |
| Luteolin-7- | 3 | 3 | 4 | False | NI | Toxic | 0.24 | 189.80 |
| Naringenin-coumaroyl-glucosid | 3 | 2 | 4 | False | NI | NT | 2.71 | 195.21 |
| Naringenin | 0 | 3 | 3 | False | Inh. | Toxic | 2.37 | 88.68 |
| Neochlorogenic acid | 3 | 4 | 4 | False | NI | NT | −0.34 | 168.42 |
| Rutin | 3 | 1 | 4 | False | NI | Toxic | −1.16 | 270.11 |
| Tricaffeoyl-altraric acid | 3 | 1 | 4 | False | NI | NT | 3.40 | 300.63 |
0, 1, 2, and 3 indicate good, moderate, low, and very low absorption, respectively; 0, 1, 2, 3, 4, and 5 indicate extremely low, very low but possible, low, good, optimal, and too soluble, respectively; 0, 1, 2, 3, and 4 denote very high, high, medium, low, and undefined penetration via BBB, respectively. PBB, plasma protein binding; false = less than 90%, true = more than 90%; NI: non-inhibitor; Inh.; inhibitor; NT: non-toxic.
Figure 5ADMET plot of E. spinosus major phenolic compounds displaying 95% and 99% confidence limit ellipses with respect to the human intestinal absorption and the blood–brain barrier (BBB) models; hispidulin (filled square); naringenin (filled star).
TOPKAT prediction of E. spinosus major phenolic compounds.
| Compounds | Ames Prediction | Rat Oral LD50 | Rat Inhalational LD50 | Rat Chronic LOAEL | Skin Irritancy | Ocular Irritancy | Rat Female NTP | Rat Male NTP | Aerobic Biodegradability |
|---|---|---|---|---|---|---|---|---|---|
| Apigenin 6-arabinoside-8-glucoside | Non-mutagen | 3.88 | 10.20 | 0.12 | None | Severe | Non-carcinogen | Non-carcinogen | Degradable |
| Apigenin-6-arabinoside-8-galactoside | Non-mutagen | 1.96 | 7.20 | 0.06 | None | Severe | Non-carcinogen | Carcinogen | Degradable |
| Chlorogenic acid | Non-mutagen | 1.97 | 93.17 | 0.03 | None | Moderate | Non-carcinogen | Non-carcinogen | Degradable |
| Coumaroyl-caffeoylquinic acid | Non-mutagen | 1.70 | 33.23 | 0.02 | None | Moderate | Non-carcinogen | Non-carcinogen | Degradable |
| Dicaffeoyl altraric acid | Non-mutagen | 7.98 | 9.59 | 0.27 | None | Severe | Non-carcinogen | Non-carcinogen | Degradable |
| Dicaffeoylquinic acid | Non-mutagen | 2.06 | 19.41 | 0.02 | None | Moderate | Non-carcinogen | Non-carcinogen | Degradable |
| Hesperidin | Non-mutagen | 2.89 | 39.63 | 0.05 | None | Mild | Non-carcinogen | Non-carcinogen | Degradable |
| Hispidulin | Non-mutagen | 0.47 | 3646.74 | 0.06 | None | Moderate | Non-carcinogen | Carcinogen | Non-degradable |
| Luteolin-7- | Non-mutagen | 1.36 | 100.48 | 0.03 | None | Moderate | Non-carcinogen | Non-carcinogen | Degradable |
| Naringenin-coumaroyl-glucosid | Non-mutagen | 2.46 | 72.35 | 0.01 | None | None | Non-carcinogen | Non-carcinogen | Degradable |
| Naringenin | Non-mutagen | 1.58 | 3435.69 | 0.08 | None | Mild | Non-carcinogen | Carcinogen | Non-degradable |
| Neochlorogenic acid | Non-mutagen | 1.97 | 93.17 | 0.03 | None | Moderate | Non-carcinogen | Non-carcinogen | Degradable |
| Rutin | Non-mutagen | 2.01 | 14.28 | 0.10 | None | Mild | Non-carcinogen | Carcinogen | Degradable |
| Tricaffeoyl-altraric acid | Non-mutagen | 11.14 | 1.79 | 0.22 | None | Severe | Non-carcinogen | Non-carcinogen | Degradable |
Both rat chronic LOAEL and rat oral LD50 are measured in g/kg bw; meanwhile, rat inhalational LD50 is measured in mg/m3/h.